source
- FDA warns Houston compounding pharmacy of unsanitary GLP-1 production risking contaminationFDA issued a warning letter to Empower Clinic Services, operating as Empower Pharmacy, after inspectors found unsanitary conditions at its Houston compounding site. Inspectors observed that the ph…
- Merck's remigromig meets visual acuity goal in diabetic macular edema trial, safety signals notedMerck announced that its experimental eye drug remigromig achieved non‑inferiority to Roche’s Lucentis in a late‑stage trial for diabetic macular edema. The trial, called Brunello, measured visual…